Literature DB >> 22022168

Cucurbitacins-type triterpene with potent activity on mouse embryonic fibroblast from Cucumis prophetarum, cucurbitaceae.

Seif-Eldin N Ayyad1, Ahmed Abdel-Lateff, Salim A Basaif, Thomas Shier.   

Abstract

BACKGROUND: Higher plants are considered as a well-known source of the potent anticancer metabolites with diversity of chemical structures. For instance, taxol is an amazing diterpene alkaloid had been lunched since 1990.
OBJECTIVE: To isolate the major compounds from the fruit extract of Cucumis prophetarum, Cucurbitaceae, which are mainly responsible for the bioactivities as anticancer.
MATERIALS AND METHODS: Plant material was shady air dried, extracted with equal volume of chloroform/methanol, and fractionated with different adsorbents. The structures of obtained pure compounds were elucidated with different spectroscopic techniques employing 1D ((1)H and (13)C) and 2D (COSY, HMQC and HMBC) NMR (Nuclear Magnetic Resonance Spectrometry) and ESI-MS (Eelectrospray Ionization Mass Spectrometry) spectroscopy. The pure isolates were tested towards human cancer cell lines, mouse embryonic fibroblast (NIH3T3) and virally transformed form (KA3IT).
RESULTS: Two cucurbitacins derivatives, dihydocucurbitacin B (1) and cucurbitacin B (2), had been obtained. Compounds 1 and 2 showed (showed potent inhibitory activities toward NIH3T3 and KA31T with IC(50) 0.2, 0.15, 2.5 and 2.0 μg/ml, respectively.
CONCLUSION: The naturally cucurbitacin derivatives (dihydocucurbitacin B and cucurbitacin B) showed potent activities towards NIH3T3 and KA31T, could be considered as a lead of discovering a new anticancer natural drug.

Entities:  

Keywords:  Cucumis prophetarum; cucurbitacin B; dihydrocucurbitacin B; mouse embryonic fibroblast and virally transformed form

Year:  2011        PMID: 22022168      PMCID: PMC3193620          DOI: 10.4103/0974-8490.85006

Source DB:  PubMed          Journal:  Pharmacognosy Res        ISSN: 0974-8490


  10 in total

Review 1.  Chemical genetics: ligand-based discovery of gene function.

Authors:  B R Stockwell
Journal:  Nat Rev Genet       Date:  2000-11       Impact factor: 53.242

Review 2.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors:  B J Druker; N B Lydon
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Further studies on the antitumor effect of cucurbitacins.

Authors:  R GALLILY; B SHOHAT; J KALISH; S GITTER; D LAVIE
Journal:  Cancer Res       Date:  1962-10       Impact factor: 12.701

4.  Studies on the antitumor effect of cucurbitacins.

Authors:  S GITTER; R GALLILY; B SHOHAT; D LAVIE
Journal:  Cancer Res       Date:  1961-05       Impact factor: 12.701

Review 5.  The cucurbitanes, a group of tetracyclic triterpenes.

Authors:  D Lavie; E Glotter
Journal:  Fortschr Chem Org Naturst       Date:  1971

6.  Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictoyota dichotoma.

Authors:  Seif-Eldin N Ayyad; Mohamed S Makki; Nazeeha S Al-Kayal; Salim A Basaif; Kalid O El-Foty; Abdullah M Asiri; Walied M Alarif; Farid A Badria
Journal:  Eur J Med Chem       Date:  2010-11-04       Impact factor: 6.514

7.  Cucurbitane-type triterpenes with anti-proliferative effects on U937 cells from an egyptian natural medicine, Bryonia cretica: structures of new triterpene glycosides, bryoniaosides A and B.

Authors:  Hisashi Matsuda; Souichi Nakashima; Osama Bashir Abdel-Halim; Toshio Morikawa; Masayuki Yoshikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  2010-05       Impact factor: 1.645

8.  Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.

Authors:  Kenneth W Yip; Xinliang Mao; P Y Billie Au; David W Hedley; Sue Chow; Shadi Dalili; Joseph D Mocanu; Carlo Bastianutto; Aaron Schimmer; Fei-Fei Liu
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

9.  Cucurbitacins: differential cytotoxicity, dereplication and first isolation from Gonystylus keithii.

Authors:  R W Fuller; J H Cardellina; G M Cragg; M R Boyd
Journal:  J Nat Prod       Date:  1994-10       Impact factor: 4.050

10.  Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.

Authors:  L L Musza; P Speight; S McElhiney; C J Barrow; A M Gillum; R Cooper; L M Killar
Journal:  J Nat Prod       Date:  1994-11       Impact factor: 4.050

  10 in total
  6 in total

1.  A Bioreductive Prodrug of Cucurbitacin B Significantly Inhibits Tumor Growth in the 4T1 Xenograft Mice Model.

Authors:  Parichat Suebsakwong; Jie Wang; Phorntip Khetkam; Natthida Weerapreeyakul; Jing Wu; Yun Du; Zhu-Jun Yao; Jian-Xin Li; Apichart Suksamrarn
Journal:  ACS Med Chem Lett       Date:  2019-09-10       Impact factor: 4.345

2.  Antibacterial and antioxidant activities of extracts and isolated compounds from the roots extract of Cucumis prophetarum and in silico study on DNA gyrase and human peroxiredoxin 5.

Authors:  Wario Galma; Milkyas Endale; Emebet Getaneh; Rajalakshmanan Eswaramoorthy; Temesgen Assefa; Yadessa Melaku
Journal:  BMC Chem       Date:  2021-05-06

3.  Exploring the Cytotoxic Potential of Triterpenoids-enriched Fraction of Bacopa monnieri by Implementing In vitro, In vivo, and In silico Approaches.

Authors:  Md Nasar Mallick; Washim Khan; Rabea Parveen; Sayeed Ahmad; Mohammad Zeeshan Najm; Istaq Ahmad; Syed Akhtar Husain
Journal:  Pharmacogn Mag       Date:  2017-10-11       Impact factor: 1.085

4.  ROS-Mediated Apoptosis Induced by BSA Nanospheres Encapsulated with Fruit Extract of Cucumis prophetarum in Various Human Cancer Cell Lines.

Authors:  Shruti Gupta; Kiran Kumar Tejavath
Journal:  ACS Omega       Date:  2021-04-06

5.  Identification of cucurbitacins and assembly of a draft genome for Aquilaria agallocha.

Authors:  Chuan-Hung Chen; Tony Chien-Yen Kuo; Meng-Han Yang; Ting-Ying Chien; Mei-Ju Chu; Li-Chun Huang; Chien-Yu Chen; Hsiao-Feng Lo; Shih-Tong Jeng; Long-Fang O Chen
Journal:  BMC Genomics       Date:  2014-07-09       Impact factor: 3.969

6.  Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.

Authors:  Abdulrhman Alsayari; Lucas Kopel; Mahmoud Salama Ahmed; Hesham S M Soliman; Sivakumar Annadurai; Fathi T Halaweish
Journal:  BMC Complement Altern Med       Date:  2018-10-09       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.